1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Oman Pharmaceuticals and Healthcare Report Q2 2016

Oman Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 74 pages

Includes 3 FREE quarterly updates

BMI View: We uphold our view that Oman's pharmaceuticals and healthcare markets will remain anattractive investment proposition for multinational pharmaceutical companies. The public sector willcontinue to fund the majority of healthcare expenditure in Oman. However, the private sector will play apivotal role in healthcare expansion over the long term as compulsory health insurance schemes gaintraction and the government looks to shift some of the financial burden. The rising cost of medical serviceswill be kept in check to an extent by the downward pressure on drug prices - mainly driven by the GCC'smedicine price unification process. Over the long term, Oman's population will benefit from moreaffordable healthcare services as price unification becomes more standardised across the Gulf States.

Headline Expenditure Projections

- Pharmaceuticals: OMR242mn (USD629mn) in 2015 to OMR258mn (USD671mn) in 2016; 6.8% inlocal currency and US dollar terms. Forecast in line with Q116.

- Healthcare: OMR942mn (USD2.45bn) in 2015 to OMR1.01bn (USD2.60bn) in 2016; +6.3% in localcurrency and US dollar terms. Forecast in line with Q116.

Table Of Contents

Oman Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Oman 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Oman 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Oman 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Oman 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Oman 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Oman 2014-2020) 30
Industry Risk/Reward Index 31
Middle East and Africa Risk/Reward Index - Q2 2016 31
Oman Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 41
Pricing Regime 42
Reimbursement Regime 44
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Oman 2010-2015) 47
Table: Healthcare Personnel (Oman 2010-2015) 48
Table: Healthcare Activity (Oman 2010-2015) 48
Research and Development 48
Clinical Trials 49
Epidemiology 50
Competitive Landscape 53
Research-Based Industry 53
Table: Multinational Market Activity 54
Generic Drugmakers 55
Pharmaceutical Distribution 56
Pharmaceutical Retail Sector 56
Company Profile 57
National Pharmaceutical Industries 57
Zynova/Oman Pharmaceutical Products Company 60
Demographic Forecast 63
Table: Population Headline Indicators (Oman 1990-2025) 64
Table: Key Population Ratios (Oman 1990-2025) 64
Table: Urban/Rural Population and Life Expectancy (Oman 1990-2025) 65
Table: Population By Age Group (Oman 1990-2025) 65
Table: Population By Age Group % (Oman 1990-2025) 66
Glossary 68
Methodology 70
Pharmaceutical Expenditure Forecast Model 70
Healthcare Expenditure Forecast Model 70
Notes On Methodology 71
Risk/Reward Index Methodology 72
Index Overview 73
Table: Pharmaceutical Risk/Reward Index Indicators 73
Indicator Weightings 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.